BioSpace News Archive

US-based biotech company VLP Therapeutics, Inc. announced that it has named Ms. Miwa Toyoda, formerly a venture capitalist specialized in pharma and biotech at JAFCO Group Co., Ltd., as chief business officer, effective March 15, in a bid to accelerate its vaccine research and development projects and expand the portfolio.

ACTIV-3 trial planned to investigate safety and efficacy of ensovibep in adults hospitalized with a COVID-19 diagnosis; first patient dose expected in Q2 2021

Libtayo is the first immunotherapy to demonstrate improved overall survival in patients with cervical cancer, reducing the risk of death by 31% compared to chemotherapy

Med tech company Pelican Diagnostics, a Canary Global Inc. company has received CE Mark for a 25-second COVID-19 saliva test, delivering real-time results with 98% sensitivity and 100% specificity.

Fast track regulatory approvals granted by government agencies to fuel research prospects is expected to widen the scope for gene therapies in the long run.

The global market for cone beam computed tomography is likely to observe a strong competition among the leading players present in the market, states a new research study that has been presented by Transparency Market Research.

With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector, observes Transparency Market Research in a recent report.

A large number of companies are present in the global surgical procedures volume market, making it fragmented.

The global ultraviolet germicidal irradiation market is estimated to witness a decent growth in the span of coming years.

OSE Immunotherapeutics and the French cooperative group ARCAGY-GINECO announced that the French National Agency for Medicines and Health Products Safety and the French Central Ethic Committee approved the initiation of a new Phase 2 clinical trial evaluating Tedopi® in patients with recurrent ovarian cancer.